Sustained treatment response of metastatic hepatocellular carcinoma with bevacizumab and sorafenib

doi:10.3748/wjg.v16.i28.3592

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 28

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2312)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series.

Item

Count

PDF

242

HTML

1919

Figures (1-5)

151

Sum=2312

Jul 28, 2010 (publication date) through Apr 30, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastroenterol. Jul 28, 2010; 16(28): 3592-3596
Published online Jul 28, 2010. doi: 10.3748/wjg.v16.i28.3592

Full Size Figure Download Figure

Figure 3 Computed tomography scans of liver (A) and thorax (B) taken in September 2008, 12 mo after initiation of sorafenib therapy showing a dramatic regression of previously described tumor lesions.

Citation: Wich C, Agaimy A, Strobel D, Wissniowski TT, Hartmann A, Ocker M. Sustained treatment response of metastatic hepatocellular carcinoma with bevacizumab and sorafenib. World J Gastroenterol 2010; 16(28): 3592-3596
URL: https://www.wjgnet.com/1007-9327/full/v16/i28/3592.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i28.3592